These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. A comparative trial of labetalol and hydralazine in the acute management of severe hypertension complicating pregnancy. Mabie WC, Gonzalez AR, Sibai BM, Amon E. Obstet Gynecol; 1987 Sep 19; 70(3 Pt 1):328-33. PubMed ID: 3306494 [Abstract] [Full Text] [Related]
11. Maternal and fetal haemodynamics in hypertensive pregnancies during maternal treatment with intravenous hydralazine or labetalol. Harper A, Murnaghan GA. Br J Obstet Gynaecol; 1991 May 19; 98(5):453-9. PubMed ID: 2059591 [Abstract] [Full Text] [Related]
13. Hemodynamic effects of intravenous hydralazine in pregnant women with severe hypertension. Kuzniar J, Skret A, Piela A, Szmigiel Z, Zaczek T. Obstet Gynecol; 1985 Oct 19; 66(4):453-8. PubMed ID: 4047535 [Abstract] [Full Text] [Related]
14. A prospective controlled trial of metoprolol-hydralazine treatment in hypertension during pregnancy. Högstedt S, Lindeberg S, Axelsson O, Lindmark G, Rane A, Sandström B, Lindberg BS. Acta Obstet Gynecol Scand; 1985 Oct 19; 64(6):505-10. PubMed ID: 3904322 [Abstract] [Full Text] [Related]
15. Effect of a beta-adrenoceptor antagonist, pindolol, on human uterine smooth muscle. Ingemarsson I, Adaikan PG, Arulkumaran S, Kottegoda SR. Gynecol Obstet Invest; 1987 Oct 19; 24(3):185-9. PubMed ID: 3692331 [Abstract] [Full Text] [Related]